Mental training program helps ease chemobrain in breast cancer
the ONA take:
A new program developed by UCLA researchers may ease post-treatment cognitive difficulties, better known as “chemo brain”, in patients with breast cancer, according to a study published in Psycho-Oncology.
In a randomized clinical trial, researchers led by Patricia Ganz, MD, built upon prior research that found a connection between neuro-psychological test performance and memory complaints in women being treated for early-stage breast cancer.
“We invited the women to participate in a research study that assigned them to early or delayed treatment with a five-week, two-hour group training session, where a psychologist taught them strategies to help them with their memory and maintaining their ability to pay attention to things,” Dr. Ganz said.
All the women who enrolled completed questions about their mood and mental functioning in follow-up testing.
Ganz and her fellow researchers found that women in the early intervention group reported improvements in memory complaints and test functioning, while those in the delayed group did not improve in either category.
“We hope that this might be an effective biologic way to assess the cognitive effects of cancer treatment in the future.”
A new program developed by UCLA researchers may ease post-treatment “chemo brain” in patients with breast cancer.
Sign Up for Free e-newsletters
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- A Witness to Letting Go: Nursing Care at the End of Life
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Modified XELIRI Noninferior to FOLFIRI for OS in Metastatic Colorectal Cancer
- Nabilone Improves Cancer-Associated Anorexia in Lung Cancer
- Direct-to-Consumer Genetic Test for Select BRCA Mutations Gets FDA Nod
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|